Novavax just announced UK and South Africa trials results:
the inevitable new era of
“Variant Addressed Studies”
89% in UK (preliminary post hoc analysis): 86% effective on UK variant
…”less so”, 49%, on South African variant (phase 2b study)…
Ongoing in US and Mexico (phase-3)
Ronzinantes 